Article
Detection of Circulating Tumor DNA in Patients with Pancreatic Cancer Using Digital Next-Generation Sequencing.
The Journal of molecular diagnostics : JMD - 1 Jun 2020
Macgregor-Das Anne, Yu Jun, Tamura Koji, Abe Toshiya, Suenaga Masaya, Shindo Koji, Borges Michael, Koi Chiho, Kohi Shiro, Sadakari Yoshihiko, Dal Molin Marco, Almario Jose A, Ford Madeline, Chuidian Miguel, Burkhart Richard, He Jin, Hruban Ralph H, Eshleman James R, Klein Alison P, Wolfgang Christopher L, Canto Marcia I, Goggins Michael
Abstract excerpt
Circulating tumor DNA (ctDNA) measurements can be used to estimate tumor burden, but avoiding false-positive results is challenging. Herein, digital next-generation sequencing (NGS) is evaluated as a ctDNA detection method. Plasma KRAS and GNAS hotspot mutation levels were measured in 140 subjects, including 67 with pancreatic ductal adenocarcinoma and 73 healthy and disease controls. To limit chemical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
